Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Macaca fascicularis | 47 | 2021 | 330 | 4.660 |
Why?
|
Postmenopause | 22 | 2019 | 398 | 3.900 |
Why?
|
Ovarian Follicle | 7 | 2014 | 23 | 2.300 |
Why?
|
Ovary | 10 | 2016 | 53 | 2.220 |
Why?
|
Animals | 73 | 2021 | 6402 | 1.870 |
Why?
|
Coronary Artery Disease | 9 | 2015 | 379 | 1.860 |
Why?
|
Atherosclerosis | 13 | 2019 | 725 | 1.800 |
Why?
|
Estrogens, Conjugated (USP) | 6 | 2014 | 125 | 1.790 |
Why?
|
Isoflavones | 15 | 2015 | 65 | 1.620 |
Why?
|
Soybean Proteins | 11 | 2015 | 64 | 1.580 |
Why?
|
Ovariectomy | 20 | 2018 | 153 | 1.480 |
Why?
|
Estrogens | 6 | 2016 | 170 | 1.390 |
Why?
|
Menopause | 8 | 2014 | 86 | 1.330 |
Why?
|
Coronary Vessels | 6 | 2015 | 161 | 1.320 |
Why?
|
Premenopause | 9 | 2019 | 37 | 1.290 |
Why?
|
Anti-Mullerian Hormone | 7 | 2017 | 15 | 1.270 |
Why?
|
Estradiol | 15 | 2018 | 120 | 1.240 |
Why?
|
Female | 74 | 2021 | 17679 | 1.210 |
Why?
|
Indoles | 4 | 2014 | 51 | 1.150 |
Why?
|
Estrogen Replacement Therapy | 5 | 2013 | 183 | 1.140 |
Why?
|
Vinyl Compounds | 4 | 2010 | 8 | 1.070 |
Why?
|
Models, Animal | 10 | 2016 | 148 | 1.040 |
Why?
|
Perimenopause | 3 | 2015 | 11 | 0.990 |
Why?
|
Receptors, Calcitriol | 2 | 2012 | 11 | 0.880 |
Why?
|
Cyclohexenes | 4 | 2010 | 12 | 0.850 |
Why?
|
Corpus Luteum | 3 | 2016 | 3 | 0.830 |
Why?
|
Selective Estrogen Receptor Modulators | 4 | 2014 | 29 | 0.830 |
Why?
|
Lipids | 9 | 2019 | 215 | 0.790 |
Why?
|
Aging | 5 | 2017 | 857 | 0.760 |
Why?
|
Diet, Atherogenic | 10 | 2015 | 61 | 0.750 |
Why?
|
Disease Models, Animal | 14 | 2021 | 915 | 0.740 |
Why?
|
Menstrual Cycle | 3 | 2018 | 28 | 0.740 |
Why?
|
Diet, Mediterranean | 4 | 2021 | 23 | 0.720 |
Why?
|
Carotid Artery Diseases | 3 | 2017 | 114 | 0.710 |
Why?
|
Iliac Artery | 8 | 2015 | 47 | 0.700 |
Why?
|
Weight Gain | 2 | 2016 | 101 | 0.670 |
Why?
|
Cholecalciferol | 3 | 2012 | 21 | 0.650 |
Why?
|
Diet | 9 | 2021 | 346 | 0.600 |
Why?
|
Biogenic Amines | 1 | 2016 | 1 | 0.590 |
Why?
|
Haplorhini | 10 | 2019 | 48 | 0.590 |
Why?
|
Carnitine | 1 | 2016 | 11 | 0.580 |
Why?
|
Norpregnenes | 4 | 2008 | 16 | 0.580 |
Why?
|
Sertraline | 4 | 2017 | 25 | 0.580 |
Why?
|
Amino Acids | 1 | 2016 | 35 | 0.580 |
Why?
|
Estrogen Receptor Modulators | 4 | 2008 | 23 | 0.580 |
Why?
|
Metabolome | 1 | 2016 | 32 | 0.570 |
Why?
|
Dietary Supplements | 4 | 2015 | 171 | 0.560 |
Why?
|
Cardiovascular Diseases | 4 | 2015 | 1059 | 0.550 |
Why?
|
C-Reactive Protein | 3 | 2012 | 236 | 0.520 |
Why?
|
Vitamin D | 2 | 2015 | 174 | 0.510 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 92 | 0.500 |
Why?
|
Reproduction | 1 | 2014 | 11 | 0.490 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2014 | 9 | 0.490 |
Why?
|
Endometriosis | 3 | 2019 | 66 | 0.460 |
Why?
|
Weight Loss | 1 | 2016 | 411 | 0.460 |
Why?
|
Calcifediol | 1 | 2012 | 7 | 0.450 |
Why?
|
Vitamin K 2 | 1 | 2012 | 1 | 0.440 |
Why?
|
Gonadal Steroid Hormones | 2 | 2010 | 28 | 0.440 |
Why?
|
Macaca mulatta | 7 | 2019 | 133 | 0.430 |
Why?
|
Vitamins | 1 | 2012 | 56 | 0.420 |
Why?
|
Energy Metabolism | 3 | 2019 | 139 | 0.420 |
Why?
|
Random Allocation | 8 | 2018 | 186 | 0.420 |
Why?
|
Cytochromes b5 | 1 | 2011 | 2 | 0.420 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 1 | 2011 | 2 | 0.420 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2011 | 3 | 0.420 |
Why?
|
Lactalbumin | 2 | 2014 | 10 | 0.420 |
Why?
|
Caseins | 2 | 2014 | 13 | 0.420 |
Why?
|
Choristoma | 1 | 2011 | 17 | 0.420 |
Why?
|
Theca Cells | 1 | 2011 | 9 | 0.420 |
Why?
|
Gene Expression | 7 | 2021 | 324 | 0.420 |
Why?
|
Androgens | 1 | 2011 | 21 | 0.410 |
Why?
|
Bone Density | 2 | 2012 | 192 | 0.410 |
Why?
|
Primates | 6 | 2021 | 70 | 0.400 |
Why?
|
Sexual Development | 1 | 2010 | 3 | 0.390 |
Why?
|
Ovarian Diseases | 1 | 2010 | 8 | 0.390 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2012 | 436 | 0.390 |
Why?
|
Breast Neoplasms | 6 | 2019 | 655 | 0.380 |
Why?
|
Arteries | 4 | 2019 | 61 | 0.380 |
Why?
|
Phytoestrogens | 5 | 2013 | 16 | 0.360 |
Why?
|
Carcinogens | 1 | 2009 | 34 | 0.350 |
Why?
|
Hyperlipoproteinemias | 1 | 2008 | 1 | 0.340 |
Why?
|
Energy Intake | 2 | 2019 | 122 | 0.340 |
Why?
|
Chronic Disease | 1 | 2010 | 359 | 0.330 |
Why?
|
Peer Review, Research | 1 | 2008 | 7 | 0.330 |
Why?
|
Soybeans | 4 | 2014 | 25 | 0.330 |
Why?
|
Serotonin Uptake Inhibitors | 3 | 2017 | 31 | 0.320 |
Why?
|
Time Factors | 7 | 2018 | 1874 | 0.300 |
Why?
|
Apoptosis | 1 | 2009 | 333 | 0.300 |
Why?
|
Cyclohexanes | 1 | 2006 | 4 | 0.300 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2015 | 441 | 0.280 |
Why?
|
Mammary Glands, Animal | 4 | 2012 | 46 | 0.280 |
Why?
|
Depression | 3 | 2017 | 361 | 0.270 |
Why?
|
Models, Biological | 3 | 2016 | 356 | 0.270 |
Why?
|
Soy Foods | 2 | 2006 | 5 | 0.260 |
Why?
|
Humans | 20 | 2021 | 28304 | 0.260 |
Why?
|
Endometrium | 4 | 2019 | 120 | 0.260 |
Why?
|
Fatty Acids | 3 | 2019 | 93 | 0.250 |
Why?
|
Immunohistochemistry | 4 | 2016 | 515 | 0.250 |
Why?
|
Injections, Intramuscular | 3 | 2009 | 39 | 0.240 |
Why?
|
Arteriosclerosis | 1 | 2003 | 126 | 0.230 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2003 | 89 | 0.230 |
Why?
|
Bone and Bones | 1 | 2004 | 88 | 0.230 |
Why?
|
Follicle Stimulating Hormone | 2 | 2014 | 19 | 0.230 |
Why?
|
Obesity | 4 | 2021 | 1079 | 0.230 |
Why?
|
Body Weight | 4 | 2016 | 289 | 0.220 |
Why?
|
Risk Factors | 6 | 2017 | 3520 | 0.220 |
Why?
|
Inflammation | 3 | 2021 | 501 | 0.200 |
Why?
|
Social Behavior | 1 | 2021 | 58 | 0.200 |
Why?
|
Cholesterol | 2 | 2018 | 231 | 0.200 |
Why?
|
Progesterone | 3 | 2016 | 76 | 0.200 |
Why?
|
Muscle, Skeletal | 2 | 2019 | 486 | 0.190 |
Why?
|
Antidepressive Agents | 2 | 2017 | 59 | 0.190 |
Why?
|
Apolipoproteins E | 2 | 2018 | 101 | 0.190 |
Why?
|
Monocytes | 1 | 2021 | 119 | 0.190 |
Why?
|
Longitudinal Studies | 4 | 2017 | 694 | 0.180 |
Why?
|
Helicobacter pylori | 1 | 2019 | 8 | 0.180 |
Why?
|
Helicobacter Infections | 1 | 2019 | 9 | 0.180 |
Why?
|
Mitochondria | 2 | 2019 | 175 | 0.180 |
Why?
|
Mitochondria, Muscle | 1 | 2019 | 17 | 0.180 |
Why?
|
Doxorubicin | 1 | 2019 | 55 | 0.180 |
Why?
|
Hippocampus | 2 | 2011 | 135 | 0.180 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 62 | 0.180 |
Why?
|
Peptides | 2 | 2018 | 116 | 0.180 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 145 | 0.170 |
Why?
|
Mammary Glands, Human | 1 | 2018 | 15 | 0.170 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2019 | 109 | 0.170 |
Why?
|
Fatty Liver | 1 | 2019 | 70 | 0.170 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2018 | 6 | 0.170 |
Why?
|
Diastole | 1 | 2018 | 96 | 0.170 |
Why?
|
Homeostasis | 1 | 2018 | 140 | 0.160 |
Why?
|
Body Composition | 2 | 2019 | 365 | 0.160 |
Why?
|
Cell Proliferation | 5 | 2015 | 567 | 0.160 |
Why?
|
Receptors, Estrogen | 2 | 2016 | 90 | 0.160 |
Why?
|
Carotid Artery, Common | 1 | 2017 | 38 | 0.160 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 467 | 0.160 |
Why?
|
Iron | 1 | 2018 | 114 | 0.160 |
Why?
|
Dietary Fats | 2 | 2015 | 107 | 0.150 |
Why?
|
Hyperandrogenism | 1 | 2017 | 2 | 0.150 |
Why?
|
Heart | 1 | 2018 | 175 | 0.150 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2017 | 19 | 0.150 |
Why?
|
Extracellular Matrix | 1 | 2018 | 225 | 0.150 |
Why?
|
Middle Aged | 6 | 2015 | 10678 | 0.150 |
Why?
|
Calcium | 1 | 2018 | 276 | 0.150 |
Why?
|
Decidua | 1 | 2016 | 18 | 0.140 |
Why?
|
Monkey Diseases | 1 | 2016 | 17 | 0.140 |
Why?
|
Hormones | 1 | 2016 | 20 | 0.140 |
Why?
|
Metabolomics | 1 | 2016 | 47 | 0.140 |
Why?
|
Infertility, Female | 1 | 2016 | 27 | 0.140 |
Why?
|
Retrospective Studies | 2 | 2016 | 2930 | 0.140 |
Why?
|
RNA, Messenger | 2 | 2015 | 498 | 0.140 |
Why?
|
Granulosa Cells | 1 | 2015 | 11 | 0.140 |
Why?
|
Neovascularization, Physiologic | 1 | 2016 | 106 | 0.140 |
Why?
|
Androstenedione | 2 | 2017 | 5 | 0.140 |
Why?
|
Blood Glucose | 2 | 2019 | 485 | 0.130 |
Why?
|
Thyroid Hormones | 1 | 2014 | 5 | 0.130 |
Why?
|
Depressive Disorder | 1 | 2015 | 68 | 0.130 |
Why?
|
Lipoproteins | 2 | 2006 | 82 | 0.130 |
Why?
|
Menstruation | 1 | 2014 | 4 | 0.120 |
Why?
|
Behavior, Animal | 1 | 2015 | 149 | 0.120 |
Why?
|
Cross-Over Studies | 3 | 2008 | 90 | 0.120 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 323 | 0.120 |
Why?
|
Basilar Artery | 1 | 2014 | 7 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 1144 | 0.120 |
Why?
|
Carotid Artery, Internal | 1 | 2014 | 20 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 2 | 2010 | 858 | 0.120 |
Why?
|
Luteinizing Hormone | 1 | 2013 | 18 | 0.120 |
Why?
|
Drug Combinations | 1 | 2014 | 83 | 0.120 |
Why?
|
Coronary Disease | 1 | 2015 | 205 | 0.120 |
Why?
|
Women's Health | 2 | 2013 | 226 | 0.120 |
Why?
|
Age Factors | 2 | 2014 | 1058 | 0.120 |
Why?
|
Drug Interactions | 1 | 2013 | 55 | 0.120 |
Why?
|
Bone Density Conservation Agents | 1 | 2013 | 20 | 0.120 |
Why?
|
MicroRNAs | 1 | 2015 | 170 | 0.110 |
Why?
|
Testosterone | 2 | 2010 | 44 | 0.110 |
Why?
|
Adipose Tissue | 1 | 2016 | 337 | 0.110 |
Why?
|
Antigens, CD | 1 | 2013 | 101 | 0.110 |
Why?
|
Hemostatics | 1 | 2012 | 12 | 0.110 |
Why?
|
Cholesterol, HDL | 3 | 2013 | 170 | 0.110 |
Why?
|
Antifibrinolytic Agents | 1 | 2012 | 15 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 151 | 0.110 |
Why?
|
Genistein | 3 | 2007 | 13 | 0.110 |
Why?
|
Epoxide Hydrolases | 1 | 2012 | 6 | 0.110 |
Why?
|
Histological Techniques | 1 | 2011 | 5 | 0.110 |
Why?
|
Cell Aging | 1 | 2011 | 1 | 0.100 |
Why?
|
Cytokines | 1 | 2013 | 239 | 0.100 |
Why?
|
Estrogen Receptor alpha | 4 | 2013 | 52 | 0.100 |
Why?
|
Anatomy, Cross-Sectional | 2 | 2010 | 14 | 0.100 |
Why?
|
Coloring Agents | 1 | 2011 | 30 | 0.100 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 147 | 0.100 |
Why?
|
Stromal Cells | 1 | 2011 | 72 | 0.100 |
Why?
|
Postoperative Care | 1 | 2011 | 70 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 67 | 0.100 |
Why?
|
Hierarchy, Social | 1 | 2010 | 12 | 0.100 |
Why?
|
Hot Flashes | 2 | 2017 | 46 | 0.100 |
Why?
|
Drug Therapy, Combination | 2 | 2008 | 279 | 0.100 |
Why?
|
Preoperative Care | 1 | 2011 | 108 | 0.100 |
Why?
|
Severity of Illness Index | 1 | 2014 | 846 | 0.100 |
Why?
|
Chemokine CCL2 | 1 | 2010 | 48 | 0.090 |
Why?
|
Antioxidants | 1 | 2011 | 117 | 0.090 |
Why?
|
Pelvis | 1 | 2010 | 61 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2010 | 224 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2010 | 700 | 0.090 |
Why?
|
Myositis | 1 | 2009 | 10 | 0.090 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 37 | 0.090 |
Why?
|
Sexual Maturation | 1 | 2009 | 18 | 0.090 |
Why?
|
Stress, Psychological | 1 | 2010 | 184 | 0.090 |
Why?
|
Body Mass Index | 1 | 2012 | 890 | 0.090 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 1345 | 0.080 |
Why?
|
Drug Stability | 1 | 2008 | 8 | 0.080 |
Why?
|
Granuloma, Foreign-Body | 1 | 2008 | 7 | 0.080 |
Why?
|
Risk | 2 | 2011 | 290 | 0.080 |
Why?
|
Cohort Studies | 1 | 2012 | 1673 | 0.080 |
Why?
|
Rats | 2 | 2009 | 1425 | 0.080 |
Why?
|
Aged | 3 | 2017 | 9256 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2017 | 2886 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 624 | 0.080 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2006 | 1 | 0.070 |
Why?
|
Genitalia, Female | 1 | 2006 | 4 | 0.070 |
Why?
|
Macaca | 2 | 2018 | 21 | 0.070 |
Why?
|
Research Design | 1 | 2008 | 271 | 0.070 |
Why?
|
Oleic Acids | 1 | 2005 | 4 | 0.070 |
Why?
|
Esters | 1 | 2005 | 9 | 0.070 |
Why?
|
Benzopyrans | 1 | 2006 | 12 | 0.070 |
Why?
|
Anticarcinogenic Agents | 1 | 2006 | 24 | 0.070 |
Why?
|
Blood Chemical Analysis | 1 | 2005 | 20 | 0.070 |
Why?
|
Male | 5 | 2018 | 16967 | 0.070 |
Why?
|
Adult | 2 | 2021 | 8243 | 0.070 |
Why?
|
Insulin | 2 | 2019 | 364 | 0.070 |
Why?
|
Feces | 2 | 2021 | 29 | 0.070 |
Why?
|
Primary Prevention | 1 | 2005 | 44 | 0.070 |
Why?
|
Follicular Phase | 2 | 2015 | 4 | 0.060 |
Why?
|
Breast | 1 | 2004 | 53 | 0.060 |
Why?
|
Hydrocortisone | 2 | 2017 | 53 | 0.060 |
Why?
|
Plant Preparations | 1 | 2004 | 21 | 0.060 |
Why?
|
Contraceptive Agents, Female | 1 | 2003 | 15 | 0.060 |
Why?
|
Contraceptives, Oral | 1 | 2003 | 20 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2003 | 35 | 0.060 |
Why?
|
Chromans | 1 | 2003 | 5 | 0.060 |
Why?
|
Hormone Replacement Therapy | 1 | 2003 | 88 | 0.060 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 221 | 0.060 |
Why?
|
Blood Pressure | 1 | 2007 | 861 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2013 | 53 | 0.060 |
Why?
|
Dietary Proteins | 2 | 2014 | 50 | 0.060 |
Why?
|
Bacteroides | 1 | 2021 | 1 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 1 | 0.050 |
Why?
|
Lactobacillus | 1 | 2021 | 8 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 283 | 0.050 |
Why?
|
Sex Factors | 1 | 2002 | 619 | 0.050 |
Why?
|
T-Lymphocytes | 2 | 2013 | 114 | 0.050 |
Why?
|
Prospective Studies | 1 | 2005 | 1932 | 0.050 |
Why?
|
Cell Size | 1 | 2019 | 27 | 0.050 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2019 | 6 | 0.050 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2019 | 6 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2012 | 139 | 0.050 |
Why?
|
Biopsy | 2 | 2012 | 240 | 0.050 |
Why?
|
Species Specificity | 1 | 2019 | 66 | 0.050 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 70 | 0.040 |
Why?
|
Fibrosis | 1 | 2019 | 112 | 0.040 |
Why?
|
Social Class | 1 | 2019 | 71 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 162 | 0.040 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 102 | 0.040 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2018 | 12 | 0.040 |
Why?
|
Radiation Dosage | 2 | 2010 | 65 | 0.040 |
Why?
|
Postoperative Period | 1 | 2018 | 89 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2018 | 81 | 0.040 |
Why?
|
Peptide Hormones | 1 | 2018 | 11 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 201 | 0.040 |
Why?
|
Anemia | 1 | 2018 | 54 | 0.040 |
Why?
|
Bone Marrow | 1 | 2018 | 59 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2018 | 102 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 102 | 0.040 |
Why?
|
Estrone | 2 | 2008 | 7 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 165 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2018 | 116 | 0.040 |
Why?
|
Cortodoxone | 1 | 2017 | 1 | 0.040 |
Why?
|
Hydroxyprogesterones | 1 | 2017 | 3 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 774 | 0.040 |
Why?
|
Myocardium | 1 | 2018 | 197 | 0.040 |
Why?
|
Corticosterone | 1 | 2017 | 7 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2018 | 392 | 0.040 |
Why?
|
Reference Values | 1 | 2017 | 227 | 0.040 |
Why?
|
Fertility | 1 | 2017 | 19 | 0.040 |
Why?
|
Prevalence | 1 | 2019 | 881 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2017 | 390 | 0.040 |
Why?
|
Carbohydrate Metabolism | 1 | 2016 | 12 | 0.040 |
Why?
|
Tissue Fixation | 1 | 2016 | 10 | 0.040 |
Why?
|
Paraffin Embedding | 1 | 2016 | 10 | 0.040 |
Why?
|
Elastin | 1 | 2016 | 14 | 0.040 |
Why?
|
Workflow | 1 | 2016 | 17 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2019 | 494 | 0.030 |
Why?
|
Frozen Sections | 1 | 2016 | 18 | 0.030 |
Why?
|
Ovulation | 1 | 2015 | 6 | 0.030 |
Why?
|
Menopause, Premature | 1 | 2015 | 8 | 0.030 |
Why?
|
Phenotype | 1 | 2017 | 653 | 0.030 |
Why?
|
Triiodothyronine | 1 | 2014 | 6 | 0.030 |
Why?
|
Thyrotropin | 1 | 2014 | 9 | 0.030 |
Why?
|
Thyroxine | 1 | 2014 | 13 | 0.030 |
Why?
|
Asian Continental Ancestry Group | 1 | 2015 | 114 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2014 | 15 | 0.030 |
Why?
|
Collagen | 1 | 2016 | 221 | 0.030 |
Why?
|
Somatomedins | 1 | 2014 | 6 | 0.030 |
Why?
|
Administration, Oral | 2 | 2005 | 163 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2014 | 40 | 0.030 |
Why?
|
Luteal Phase | 1 | 2013 | 17 | 0.030 |
Why?
|
Endometrial Hyperplasia | 1 | 2013 | 14 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 161 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2013 | 34 | 0.030 |
Why?
|
Collagen Type I | 1 | 2013 | 39 | 0.030 |
Why?
|
Mice | 1 | 2018 | 2181 | 0.030 |
Why?
|
Disease Progression | 1 | 2015 | 566 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 29 | 0.030 |
Why?
|
RNA | 1 | 2013 | 83 | 0.030 |
Why?
|
Eicosanoids | 1 | 2012 | 5 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2012 | 11 | 0.030 |
Why?
|
Cytosol | 1 | 2012 | 25 | 0.030 |
Why?
|
Urea | 1 | 2012 | 31 | 0.030 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2011 | 5 | 0.030 |
Why?
|
Phospholipases A2 | 1 | 2011 | 22 | 0.030 |
Why?
|
Claudins | 1 | 2011 | 9 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2011 | 21 | 0.030 |
Why?
|
Cadherins | 1 | 2011 | 24 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2011 | 43 | 0.030 |
Why?
|
Macrophages | 1 | 2013 | 183 | 0.030 |
Why?
|
Piperidines | 1 | 2012 | 84 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 89 | 0.030 |
Why?
|
Analgesics | 1 | 2012 | 101 | 0.020 |
Why?
|
Menstruation Disturbances | 1 | 2010 | 3 | 0.020 |
Why?
|
Anovulation | 1 | 2010 | 5 | 0.020 |
Why?
|
Bone Diseases, Metabolic | 1 | 2010 | 18 | 0.020 |
Why?
|
Dexamethasone | 1 | 2010 | 39 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2010 | 151 | 0.020 |
Why?
|
Contrast Media | 1 | 2010 | 123 | 0.020 |
Why?
|
Organ Size | 1 | 2010 | 204 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 1556 | 0.020 |
Why?
|
P-Selectin | 1 | 2008 | 11 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 17 | 0.020 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2008 | 14 | 0.020 |
Why?
|
Social Dominance | 1 | 2008 | 8 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2008 | 43 | 0.020 |
Why?
|
Liver | 1 | 2012 | 466 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 378 | 0.020 |
Why?
|
Compliance | 1 | 2007 | 14 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2007 | 24 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2007 | 30 | 0.020 |
Why?
|
Radiometry | 1 | 2007 | 37 | 0.020 |
Why?
|
Intestines | 1 | 2007 | 54 | 0.020 |
Why?
|
Bacteria | 1 | 2007 | 44 | 0.020 |
Why?
|
Laboratory Animal Science | 1 | 2006 | 1 | 0.020 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2006 | 9 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2007 | 480 | 0.020 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2006 | 10 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 2006 | 23 | 0.020 |
Why?
|
Pterocarpans | 1 | 2006 | 4 | 0.020 |
Why?
|
Fluoroimmunoassay | 1 | 2005 | 1 | 0.020 |
Why?
|
Hysterectomy | 1 | 2006 | 37 | 0.020 |
Why?
|
Vagina | 1 | 2006 | 46 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2005 | 25 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2006 | 44 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 236 | 0.020 |
Why?
|
Uterus | 1 | 2006 | 74 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 521 | 0.020 |
Why?
|
Biological Availability | 1 | 2004 | 19 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2004 | 21 | 0.020 |
Why?
|
Kanamycin | 1 | 2003 | 1 | 0.010 |
Why?
|
Vancomycin | 1 | 2003 | 19 | 0.010 |
Why?
|
Metronidazole | 1 | 2003 | 15 | 0.010 |
Why?
|
Doxycycline | 1 | 2003 | 25 | 0.010 |
Why?
|
Mesocricetus | 1 | 2002 | 3 | 0.010 |
Why?
|
Cricetinae | 1 | 2002 | 54 | 0.010 |
Why?
|